Clinuvel Pharmaceuticals
Australia - MelbournePharmaceutical
Focus: Clinuvel is an Australia-based pharmaceutical company focused on small molecule development, primarily advancing afamelanotide across multiple dermatological, neurological, and rare disease indications. The company operates a focused pipeline with significant Phase 2-3 depth in niche therapeutic areas.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Clinuvel Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Clinuvel Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
6 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Afamelanotide
Polymorphic Light Eruption (PLE)Clinical Trials (1)
NCT00472901Phase III Trial of CUV1647 in Polymorphic Light Eruption (PLE)
N/AHelp build intelligence for Clinuvel Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.